Trending...
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
- On the Boards: Proform Builds Announce New Construction in Alki, Seattle
- On the Boards: Proform Builds Announce New Construction in Gig Harbor
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global bone tumor ablation devices market is estimated to be valued at US$ 56.2 million in 2020 and is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027).
Key Trends and Analysis of the Global Bone Tumor Ablation Devices Market:
Successful and multiple use of the microwave ablation technique for the treatment of various diseases is expected to increase the sales of bone tumor ablation devices worldwide, thereby strengthening the position of the companies in the global market. For instance, according to the doctors at National Taiwan University are successfully using microwave energy to minimally invasively treat tumors in the lung with higher local success rate of 84% compared to historical 67-78% reported, as of December 2019.
Major companies in the Europe region are involved in various growth strategies such collaboration, acquisition for research and development of new technology, in order to enhance their market presence. For instance, Medtronic plc acquired OsteoCool device technology from Baylis Medical in 2015.
Various key players in the market are entering the market through inorganic growth strategies such as mergers and acquisitions. For instance, in August 2020, Olympus Corporation announced signing of a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. Under the agreement, Olympus will acquire Arc Medical Design and obtain full rights of its medical products. Post-acquisition, Olympus Corporation is planning to design, manufacture, and distribute the products worldwide.
More on Washingtoner
Furthermore, rising adoption of ablation devices by the surgeons for treatment in different therapeutic categories is expected to drive growth of the market in the Middle East. For instance, in 2019, IceCure Medical, an Israel-based company, received Israeli AMAR authorization (an Israeli Ministry of Health's medical device regulation unit) to use its freezing technology in treatment of benign and malignant tumors of bones, liver, lymphatic tissue, lymph nodes, and endocrine glands.
Request Sample Copy of this Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4319
Key Market Takeaways:
The global bone tumor ablation devices market is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027), owing to the rising prevalence of bone cancer, or rare bone disorders worldwide. For instance, according to the National Organization for Rare Disorders, Ewing sarcoma affects males more often than females. It may affect individuals of any age, but most often occurs in individuals between 10 and 20 years of age. The annual incidence of Ewing sarcoma is 2.93 children per 1,000,000 in the U.S. Around 200-250 children and adolescents in the U.S. are diagnosed with a tumor in the Ewing family of tumors, each year.
Competitive Landscape:
Key players in the North America bone tumor ablation devices market are focused on development of various bone tumor ablation devices, which is expected to drive growth of the market during the forecast period. For instance, in December 2015, DFINE, Inc., announced the commercial launch of its Long SpineSTAR Ablation Instrument. Long SpineSTAR is the latest innovation by the Silicon Valley medical device manufacturer and is part of the company's flagship STAR Tumor Ablation System.
More on Washingtoner
Key players operating in the global bone tumor ablation devices market include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.
Buy-Now this Research Report for detailed market insights: https://www.coherentmarketinsights.com/insight/buy-now/4319
Bone Tumor Ablation Devices Market Segmentation:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.
Key Trends and Analysis of the Global Bone Tumor Ablation Devices Market:
Successful and multiple use of the microwave ablation technique for the treatment of various diseases is expected to increase the sales of bone tumor ablation devices worldwide, thereby strengthening the position of the companies in the global market. For instance, according to the doctors at National Taiwan University are successfully using microwave energy to minimally invasively treat tumors in the lung with higher local success rate of 84% compared to historical 67-78% reported, as of December 2019.
Major companies in the Europe region are involved in various growth strategies such collaboration, acquisition for research and development of new technology, in order to enhance their market presence. For instance, Medtronic plc acquired OsteoCool device technology from Baylis Medical in 2015.
Various key players in the market are entering the market through inorganic growth strategies such as mergers and acquisitions. For instance, in August 2020, Olympus Corporation announced signing of a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. Under the agreement, Olympus will acquire Arc Medical Design and obtain full rights of its medical products. Post-acquisition, Olympus Corporation is planning to design, manufacture, and distribute the products worldwide.
More on Washingtoner
- Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
- Gravity Payments and Suno Software Partner to Simplify Payments for Independent Hearing Clinics
- Where Do Missouri Plane Crashes Really Happen? Not Where You'd Think
- Spokane: Female Arrested After Homeowners Caught Her on Property of Burned Home
- SPD Detectives are Investigating a Suspicious Death in West Spokane
Furthermore, rising adoption of ablation devices by the surgeons for treatment in different therapeutic categories is expected to drive growth of the market in the Middle East. For instance, in 2019, IceCure Medical, an Israel-based company, received Israeli AMAR authorization (an Israeli Ministry of Health's medical device regulation unit) to use its freezing technology in treatment of benign and malignant tumors of bones, liver, lymphatic tissue, lymph nodes, and endocrine glands.
Request Sample Copy of this Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4319
Key Market Takeaways:
The global bone tumor ablation devices market is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027), owing to the rising prevalence of bone cancer, or rare bone disorders worldwide. For instance, according to the National Organization for Rare Disorders, Ewing sarcoma affects males more often than females. It may affect individuals of any age, but most often occurs in individuals between 10 and 20 years of age. The annual incidence of Ewing sarcoma is 2.93 children per 1,000,000 in the U.S. Around 200-250 children and adolescents in the U.S. are diagnosed with a tumor in the Ewing family of tumors, each year.
Competitive Landscape:
Key players in the North America bone tumor ablation devices market are focused on development of various bone tumor ablation devices, which is expected to drive growth of the market during the forecast period. For instance, in December 2015, DFINE, Inc., announced the commercial launch of its Long SpineSTAR Ablation Instrument. Long SpineSTAR is the latest innovation by the Silicon Valley medical device manufacturer and is part of the company's flagship STAR Tumor Ablation System.
More on Washingtoner
- LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
- Spokane: City Council Approves Mayor's Orders for Declaration of Emergency
- Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
Key players operating in the global bone tumor ablation devices market include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.
Buy-Now this Research Report for detailed market insights: https://www.coherentmarketinsights.com/insight/buy-now/4319
Bone Tumor Ablation Devices Market Segmentation:
- By Technology:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- By Indication:
- Osteosarcoma
- Chondrosarcoma
- Ewing's Sarcoma
- Metastatic Bone Cancer Bone Cancer Bone Cancer
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- By Region:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- North America
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.
0 Comments
Latest on Washingtoner
- The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
- Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
- Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
- Stage 2 Burn Ban Order in Effect Across Tacoma
- San Diego Attorney Anthony Z. Vargas Narrows Practice to Employment Law, Representing Employees Only
- Spokane: Additional PPE Kits Available Tuesday and Thursday
- Solid Earth Introduces RealtyID, a Universal Identity Spine for the Real Estate Industry
- BlazeHive's AI SEO Agent Outranks Human Writers on 500+ Google Top-3 Results in 5 Months, on Autopilot
- Cracking the Immortality Code: A Human / AI Long-Term Collaboration Working to Achieve Immortality
- On the Boards: Proform Builds Announce New Construction in Alki, Seattle
- On the Boards: Proform Builds Announce New Construction in Gig Harbor
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
- Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
- Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
- Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
- DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
- Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
- Permian Museum announces the addition of an Ancient Alien Artifacts photo gallery
- VISION 2050 Award for Historic Tideflats Subarea Plan Presented by Puget Sound Regional Council at Tacoma City Council Meeting